arrow_back close
News & Events
The EFPIA view
Driving Reinvestment... Driving Reinvestment in R&D and responsible Antibiotic use (DRIVE-AB)
close

Driving Reinvestment in R&D and responsible Antibiotic use (DRIVE-AB)

27.10.14
Geneva, Switzerland, 27. October 2014 – A major new European initiative to tackle the growing global threat of antibiotic resistance began this month with the launch of DRIVE-AB (Driving Reinvestment in R&D and Responsible Antibiotic Use).

Read the full DRIVE-AB (Driving Reinvestment in R&D and Responsible Antibiotic Use) press release here.

close
continue